Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Ultrasound Acute Chest Syndrome Sickle Cell Disease

NCT: NCT06880679 · RECRUITING

NCT IDNCT06880679
StatusRECRUITING
Start Date2025-04-08
Completion2026-06-30

Brief Summary

Feasibility and reliability of ultrasound in the inpatient hematology setting.

Frequently Asked Questions

What is Ultrasound Acute Chest Syndrome Sickle Cell Disease?

Ultrasound Acute Chest Syndrome Sickle Cell Disease is a clinical trial registered under NCT06880679. Current status: RECRUITING.

What is the status of NCT06880679?

The current status of NCT06880679 (Ultrasound Acute Chest Syndrome Sickle Cell Disease) is: RECRUITING.

When did Ultrasound Acute Chest Syndrome Sickle Cell Disease start?

Ultrasound Acute Chest Syndrome Sickle Cell Disease started on 2025-04-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.